ASP | Hepatoprotective | Reduce lipid accumulation and fatty regeneration | [85] |
ASP | Hepatoprotective | Alleviates chronic liver fibrosis by inhibiting hepatic stellate cell activation through the IL-22/STAT3 pathway | [86] |
ASP | Hepatoprotective | Suppress lipid peroxidation and oxidative stress, along with the inhibition of apoptosis to improve acetaminophen-induced acute liver injury | [86-87] |
ASP | Hepatoprotective | High liver specificity due to affinity for asialoglycoprotein receptors, aiding in drug delivery to the liver | [88] |
Angelica polysaccharide | Anti-inflammatory and immunomodulatory | Repress NF-κB and JAK2/STAT3 pathways by regulating miR-10a to mitigate LPS-evoked inflammatory injury | [89] |
ASP | Anti-inflammatory and immunomodulatory | Activate ERK1/2-dependent autophagy in chondrocytes to rescue SNP-induced apoptosis | [90] |
ASP | Anti-inflammatory and immunomodulatory | Inhibit myeloperoxidase activity, pro-inflammatory cytokine expression, and apoptosis to relieve dextran sodium sulfate-induced colitis | [91] |
ASP | Anti-inflammatory and immunomodulatory | Enhances activation of immune cells and cytokine secretion, acting as an immune enhancer | [92] |
Angelica polysaccharide | Anti-inflammatory and immunomodulatory | Upregulates immune cell and enhances immune response through STAT1 and STAT3 signaling pathways | [93] |
ASP | Anti-inflammatory and immunomodulatory | Stimulates strong immune responses when encapsulated with OVA in nanoparticle carriers as vaccine adjuvant | [94] |
ASP | Anti-tumor | Repress tumorigenesis of neuroblastoma cell line SH-SY5Y cells through miR-675-mediated inactivation of the PI3K/AKT and JAK/STAT pathways | [95] |
ASP | Anti-tumor | Decrease hepcidin expression, which can reduce iron burden and inhibit tumor proliferation through JAK/STAT and bone morphogenetic protein (BMP)-mothers against decapentaplegic homolog (SMAD) pathways | [96] |
ASP | Anti-tumor | Promote apoptosis of leukemia cells | [19] |
ASP | Anti-tumor | Serves as a targeted drug delivery carrier, to improve tumor microenvironment and enhance immune function, resulting in synergistic antitumor effect with chemotherapy drugs | [97] |
ASP | Anti-tumor | Serves as a drug delivery carrier targeting liver cancer, generates superior antitumor activity | [98] |
Z-LIG | Anti-tumor | Induce ovarian cancer cell death by inducing oxidative stress | [99] |
Z-LIG | Anti-tumor | Enhances tamoxifen therapy in resistant breast cancer by inhibiting autophagy. | [100] |
ASP | Hematopoietic | Prevent the JAK, SMAD and ERK pathways to down-regulate hepcidin | [101] |
ASP | Hematopoietic | Restore erythropoietin (EPO) production and improve iron availability by blocking GATA-binding factor 2 (GATA2) and NF-κB activation | [102] |
ASP | Hematopoietic | Delay oxidative stress-induced premature senescence of 5-fluorouracil-treated feeder co-cultured hematopoietic cells via down-regulation of over-activated Wnt/β-catenin signaling | [103] |
ASP | Hematopoietic | Promote the expression of cyclinD2 mRNA, downregulate the surface content of CD44 and CD49d on mononuclear cells in the bone marrow | [104-106] |
ASP | Hematopoietic | Regulate mitochondrial function to reduce ROS, MDA, and MAO levels, and inhibit excessive apoptosis of hematopoietic stem cells | [107] |
ASP | Hematopoietic | Reduce oxidative stress and apoptosis via reactivation of nuclear factor erythroid 2-related factor 2 (Nrf2) and PI3K/AKT pathways | [108] |
Volatile oil | Vasodilation and antihypertensive | Inhibit the release of calcium ions and the influx of external calcium, reduce ET-1, and increase NO to relax blood vessels | [109-110] |
Volatile oil | Vasodilation and antihypertensive | Inhibit inflammatory and oxidative pathways, suppress the generation of VCAM-1 and C-reactive protein, and enhance the levels of SOD and CAT | [111] |
Volatile oil | Vasodilation and antihypertensive | Downregulate the expression of AT1R and the vascular endothelial tissue SLC7A1 through miR122, antagonizing the renin-angiotensin system to regulate vascular endothelial signaling factors | [112-113] |
A. sinensis injection | Vasodilation and antihypertensive | Inhibit the overexpression of transforming growth factor-beta 1 (TGF-β1)/PI3K pathway in liver tissue, reduce portal vein pressure, and regulate changes in portal vein hemodynamics | [114] |
Volatile oil | Vasodilation and antihypertensive | Regulate the PI3K/Akt/endothelial nitric oxide synthase (eNOS) signaling pathway to reduce blood pressure | [115] |
A. sinensis | Anticoagulation and anti-thrombotic | Inhibit adenosine diphosphate- or arachidonic acid-induced platelet aggregation | [116] |
A. sinensis extract | Neuroprotective | Activate p38 MAPK-mediated p90 ribosomal S6 kinase (p90RSK)/phosphorylated Bcl-2-associated death promoter (p-Bad)-induced anti-apoptotic-Cytc/caspase-3-related and p90RSK/ cAMP-response element binding protein (CREB)/brain-derived neurotrophic factor (BDNF) survival signaling pathways | [117] |
A. sinensis extract | Neuroprotective | activation of p38 MAPK-mediated CREB/BDNF, glial cell line-derived neurotrophic factor (GDNF), and VEGF-A signaling pathways | [118] |
LIG | Neuroprotective | Penetrates blood-brain barrier, providing potential protective effects on the nervous system | [119] |
LIG | Neuroprotective | Induct α-processing of APP and Klotho and potential Aβ clearance | [120] |
Z-LIG | Neuroprotective | Inhibit p38 and activation of PI3K/Akt signaling pathways concurrently to improve Aβ fibrils-induced neurotoxicity | [121] |